FANCM
Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| FA complementation group M | MIM:609644 | Ensembl:ENSG00000187790 | HGNC:HGNC:23168 | PA134943156 | 14q21.2 |
Gene Categories:
DNA REPAIRGO terms in FANCM
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0003677 | DNA binding |
| MF | IDA | GO:0003682 | chromatin binding |
| MF | IEA | GO:0004386 | helicase activity |
| MF | IEA | GO:0004518 | nuclease activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| CC | IDA | GO:0005654 | nucleoplasm |
| CC | TAS | GO:0005654 | nucleoplasm |
| CC | IDA | GO:0043240 | Fanconi anaemia nuclear complex |
| CC | IDA | GO:0071821 | FANCM-MHF complex |
| BP | IMP | GO:0000712 | resolution of meiotic recombination intermediates |
| BP | IMP | GO:0031297 | replication fork processing |
| BP | TAS | GO:0036297 | interstrand cross-link repair |
| BP | IEA | GO:0090305 | nucleic acid phosphodiester bond hydrolysis |
Gene expression in normal tissue: FANCM
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in FANCM
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| kegg | hsa03460 | Fanconi anemia pathway - Homo sapiens (human) |
| pid | fanconi_pathway | Fanconi anemia pathway |
| reactome | R-HSA-6783310 | Fanconi Anemia Pathway |
| reactome | R-HSA-73894 | DNA Repair |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD255 | SB225002 | 2 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 3 |
| iGMDRD188 | Piperlongumine | 3 |
| iGMDRD398 | Sepantronium | 3 |
| iGMDRD562 | Navitoclax | 4 |
| iGMDRD577 | BIX01294 | 2 |
| iGMDRD640 | CAY10618 | 1 |
| iGMDRD356 | PNU-74654 | 2 |
| iGMDRD387 | CHIR-99021 | 3 |
| iGMDRD427 | ABT737 | 2 |
| iGMDRD781 | Sirolimus | 2 |
| iGMDRD483 | SCH-529074 | 3 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD639 | YK 4-279 | 1 |
| iGMDRD679 | Bistramide A | 4 |
| iGMDRD280 | CYTOCHALASIN B | 7 |
| iGMDRD466 | Chaetocin | 6 |
| iGMDRD634 | SCHEMBL2608041 | 2 |
| iGMDRD202 | Curcumin | 1 |
| iGMDRD103 | SN-38 | 2 |
| iGMDRD434 | BMS-536924 | 2 |
| iGMDRD105 | Triptolide | 2 |
| iGMDRD267 | Oligomycin A | 4 |
| iGMDRD481 | Dactolisib | 3 |
| iGMDRD872 | BRD7137 | 2 |
| iGMDRD414 | MST-312 | 2 |
| iGMDRD366 | PI-103 | 3 |
| iGMDRD505 | Pevonedistat | 4 |
| iGMDRD486 | Tosedostat | 1 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD248 | BRD4354 | 1 |
| iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
| iGMDRD150 | RITA | 8 |
| iGMDRD701 | NVP-AUY922 | 2 |
| iGMDRD79 | Gemcitabine | 2 |
| iGMDRD85 | Ursolic acid | 2 |
| iGMDRD57 | Chloropentafluorobenzene | 2 |
| iGMDRD351 | GW843682X | 2 |
| iGMDRD211 | (1S,3R)-RSL3 | 2 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD154 | NSC23766 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in FANCM
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.